Delta-fly Pharma, Inc. (4598) Press Release
Update on the Phase 2／3 Clinical Trial of DFP-17729
Earlier from Delta-fly Pharma
- Delta-Fly Pharma, Inc.: Progress of Development Status of the Combination Study of DFP-10917 with Venetoclax
- Delta-Fly Pharma Inc.: Update for Development Status of the Combination Study of DFP-10917 with Venetoclax
- Delta-Fly Pharma Inc.: Update for Development Status of DFP-17729
- Delta-Fly Pharma Inc.: Progress Update of the Phase III Clinical Trial of DFP-14323